Patents Assigned to UCL Business PLLC
  • Composition comprising a cell death marker and a wavelength-optimized label
    Patent number: 8771645
    Abstract: The invention relates to the use of a cell death marker labelled with a wavelength-optimised label for identifying cell death in the eye. Suitable cell death markers are the Annexins and fragments and derivatives thereof. The invention also relates to a pharmaceutical composition comprising a cell death marker labelled with a wavelength-optimised label and a method for monitoring cell death in the eye using a cell death marker labelled with a wavelength-optimised label.
    Type: Grant
    Filed: December 15, 2008
    Date of Patent: July 8, 2014
    Assignee: UCL Business PLLC
    Inventors: Francesca Cordeiro, Stephen Moss, Frederick Fitzke